AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 26, 2011

Primary Completion Date

June 6, 2011

Study Completion Date

June 6, 2011

Conditions
Psoriasis
Interventions
DRUG

AN2728 ointment, 2%

AN2728 ointment, 2%, applied twice daily for 12 weeks

DRUG

Ointment Vehicle

Ointment Vehicle, applied twice daily for 12 weeks

Trial Locations (10)

27262

Dermatology Consulting Services, High Point

40202

Dermatology Specialists, PSC, Louisville

77056

The Center for Skin Research, Houston

77845

J&S Studies, Inc., College Station

78759

DermResearch, Inc, Austin

87106

Academic Dermatology Associates, Albuquerque

89052

Karl G. Heine, MD Dermatology, Henderson

97223

Oregon Medical Research Center, Portland

06511

The Savin Center, New Haven

55432-3133

Minnesota Clinical Study Center, Fridley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY